semaglutide fda ruling Judge Upholds Deadline Ending Production of Compounded Ozempic and Wegovy FDA says 'no clinical need'

This isn't just about following rules

Major barriers to the clinical use of gene therapy, however, include transfection efficiency, the creation of long-term effects, the difficulty of controlling cell proliferation, ectopic transfection, disease transmission, patient-specific dose responses, immune reactions against viral proteins, possible side effects, and ethical issues [87, 88]

Recent studies have shown the incredible potential of GLP-1 medications in preventing, managing, and even reversing type 2 diabetes: People with prediabetes who took Semaglutide achieved significant weight loss and improved blood sugar levels, reducing their risk of progressing to type 2 diabetes

The mechanism of regulation of each isoforms by different stresses and developmental stages is yet to be completely understood